Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului
Yüklə 4,39 Mb.
|
Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J06BB16 PALIVIZUMABUM PULB. + SOLV. PT. SOL. 100 mg INJ. SYNAGIS 100 mg 100 mg ABBOTT LABORATORIES LTD. J06BB16 PALIVIZUMABUM PULB. + SOLV. PT. SOL. 50 mg INJ.
SYNAGIS 50 mg 50 mg ABBOTT LABORATORIES LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 681 |L03AA02| FILGRASTIMUM (G-CSF)** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L03AA02 FILGRASTIMUM (G-CSF) SOL. INJ. 30 MU/0.5 ml NEUPOGEN(R) 30 MU/0.5 ml AMGEN EUROPE B.V.
NEUPOGEN(R) 48 MU/0.5 ml AMGEN EUROPE B.V. ________________________________________________________________________________
| 682 |S01AA23| NETILMICINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S01AA23 NETILMICINUM PICATURI OFT. - SOL. 0.3% NETTACIN(R) 0.3% S.I.F.I. SPA
NETTAVISC 3 mg/g 3 mg/g S.I.F.I. SPA S01AA23 NETILMICINUM PIC. OFT., SOL 0.3% NETTACIN(R) 0.3% S.I.F.I. SPA ________________________________________________________________________________
| 683 |S01AX17| LOMEFLOXACINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S01AX17 LOMEFLOXACINUM PICATURI OFT. - SOL. 3 mg/ml OKACIN 3 mg/ml NOVARTIS PHARMA GMBH ________________________________________________________________________________ ______________________________________________________________________________ | 684 |S03AAN2| NORFLOXACINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S03AAN2 NORFLOXACINUM PICATURI OFT./ 0.3% AURIC. - SOL NORFLOX 0.3% CIPLA (UK) LIMITED ________________________________________________________________________________
| 685 |S01BA01| DEXAMETHASONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ S01BA01 DEXAMETHASONUM PICATURI OFT. - SUSP. 0.1% MAXIDEX(R) 0.1% ALCON COUVREUR NV
DEXAMETAZONA RPH 1 mg/ml ROMPHARM COMPANY SRL 1 mg/ml ________________________________________________________________________________ ______________________________________________________________________________ | 1207 |J02AA01| AMPHOTERICINUM B LIPOSOMAL (4) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AA01 AMPHOTERICINUM B LIPOSOMAL ________________________________________________________________________________ ______________________________________________________________________________ | 1208 |P01AX06| ATOVAQUONA (4) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ P01AX06 ATOVAQUONA ________________________________________________________________________________
| 1209 |J02AX01| FLUCYTOSINUM (4) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AX01 FLUCYTOSINUM ________________________________________________________________________________
| 1210 |P01BC02| MEFLOQUINE (4) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ P01BC02 MEFLOQUINE ________________________________________________________________________________
| 1211 |R01AX06| MUPIROCINUM (4) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ R01AX06 MUPIROCINUM ________________________________________________________________________________
| 1212 |A07AA06| PAROMOMYCINUM (4) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ A07AA06 PAROMOMYCINUM ________________________________________________________________________________
| 1213 |P01CX01| PENTAMIDINUM (4) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ P01CX01 PENTAMIDINUM ________________________________________________________________________________
| 1214 |P01BA03| PRIMAQUINUM (4) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ P01BA03 PRIMAQUINUM ________________________________________________________________________________
| 1215 |P01BD01| PYRIMETHAMINUM (4) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ P01BD01 PYRIMETHAMINUM ________________________________________________________________________________
| 1216 |P01BD51| PYRIMETHAMINUM + SULFADIAZINUM (4) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ P01BD51 PYRIMETHAMINUM + SULFADIAZINUM ________________________________________________________________________________ ______________________________________________________________________________ | 1217 |J01EA01| TRIMETHOPRIM (4) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01EA01 TRIMETHOPRIM ________________________________________________________________________________
| 686 |A11HA02| PYRIDOXINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ A11HA02 PYRIDOXINUM COMPR. 250 mg VITAMINA B6 250 mg 250 mg ARENA GROUP SA
SICOVIT B6 250 mg 250 mg ZENTIVA SA A11HA02 PYRIDOXINUM SOL. INJ. 250 mg/5 ml SICOVIT B6 250 mg/5 ml 250 mg/5 ml ZENTIVA SA A11HA02 PYRIDOXINUM SOL. INJ. 50 mg/2 ml SICOVIT B6 50 mg/2 ml 50 mg/2 ml ZENTIVA SA ________________________________________________________________________________
| 687 |H02AB07| PREDNISONUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ H02AB07 PREDNISONUM COMPR. 5 mg N - PREDNISON 5 mg MEDUMAN SA PREDNISON 5 mg 5 mg SINTOFARM SA PREDNISON ARENA 5 mg 5 mg ARENA GROUP SA PREDNISON GEDEON RICHTER 5 mg 5 mg GEDEON RICHTER ROMANIA SA PREDNISON MAGISTRA 5 mg 5 mg MAGISTRA C & C ________________________________________________________________________________ ______________________________________________________________________________ | 688 |J01FA09| CLARITHROMYCINUM | | |_______|_______|____________________________________________|_________________| ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALA 125 mg/5 ml FROMILID(R) 125 mg/5 ml 125 mg/5 ml KRKA D.D. KLABAX 125 mg/5 ml 125 mg/5 ml TERAPIA S.A. KLACID(R) 125 mg/5 ml ABBOTT SPA LEKOKLAR 125 mg/5 ml 125 mg/5 ml SANDOZ S.R.L J01FA09 CLARITHROMYCINUM COMPR. FILM. 250 mg CLAR 250 250 mg MEDICAROM GROUP S.R.L. CLARITROMICINA 250 mg 250 mg OZONE LABORATORIES LTD. FROMILID 250 250 mg KRKA D.D. NOVO MESTO KLABAX 250 mg 250 mg TERAPIA S.A. KLACID(R) 250 mg ABBOTT SPA KLERIMED(R) 250 250 mg MEDOCHEMIE LTD. LEKOKLAR(R) 250 mg 250 mg LEK PHARMACEUTICALS D.D. J01FA09 CLARITHROMYCINUM GRAN. PT. SUSP. ORALA 250 mg/5 ml KLABAX 250 mg/5 ml 250 mg/5 ml TERAPIA S.A. LEKOKLAR 250 mg/5 ml 250 mg/5 ml SANDOZ SRL
CLAR 500 500 mg MEDICAROM GROUP S.R.L. CLARITROMICINA 500 mg 500 mg OZONE LABORATORIES LTD. FROMILID 500 500 mg KRKA D.D. NOVO MESTO KLABAX 500 mg 500 mg TERAPIA S.A. KLERIMED(R) 500 500 mg MEDOCHEMIE LTD. LEKOKLAR(R) 500 mg 500 mg LEK PHARMACEUTICALS D.D.
MODIF.
KLABAX MR 500 mg 500 mg TERAPIA S.A. LEKOKLAR XL 500 mg 500 mg LEK PHARMACEUTICALS D.D. J01FA09 CLARITHROMYCINUM COMPR. FILM. ELIB. PREL 500 mg FROMILID(R) UNO 500 mg KRKA D.D. KLACID SR 500 mg ABBOTT LABORATORIES LTD.
KLACID I.V. 500 mg ABBOTT LABORATORIES LTD. ________________________________________________________________________________
| 691 |J01GB06| AMIKACINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01GB06 AMIKACINUM SOL. INJ. 100 mg/2 ml AMIKOZIT(R) 100 mg/2 ml 100 mg/2 ml ECZACIBASI PHARMACEUTICALS S.R.L.
AMIKIN 250 mg/ml BRISTOL MYERS SQUIBB KFT
AMIKOZIT(R) 500 mg/2 ml 500 mg/2 ml ECZACIBASI PHARMACEUTICALS S.R.L. ________________________________________________________________________________ ______________________________________________________________________________ | 692 |J01MA01| OFLOXACINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01MA01 OFLOXACINUM COMPR. FILM. 200 mg OFLOXACIN 200 mg 200 mg ANTIBIOTICE SA OFLOXIN 200 200 mg ZENTIVA AS ZANOCIN 200 mg RANBAXY UK LIMITED
ELIB. PREL. ZANOCIN(R) OD 400 400 mg RANBAXY U.K. LIMITED ________________________________________________________________________________ ______________________________________________________________________________ | 693 |J01MA02| CIPROFLOXACINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01MA02 CIPROFLOXACINUM CONC. PT. SOL. PERF. 100 mg/10 ml CIPRINOL(R) 100 mg/10 ml KRKA D.D. CIPROFLOXACINA 100 mg/10 ml 100 mg/10 ml SICOMED SA J01MA02 CIPROFLOXACINUM SOL. PERF. 100 mg/50 ml CIPRINOL 100 mg/50 ml KRKA D.D. NOVO MESTO J01MA02 CIPROFLOXACINUM SOL. PERF. 200 mg/100 ml CIPRINOL 200 mg/100 ml KRKA D.D. NOVO MESTO CIPROBAY(R) 200 200 mg/100 ml BAYER HEALTHCARE AG
EUCIPRIN 250 mg EUROPHARM SA J01MA02 CIPROFLOXACINUM COMPR. FILM. 250 mg CIFRAN 250 mg RANBAXY UK LIMITED CIPHIN 250 250 mg ZENTIVA A.S. CIPRINOL 250 mg 250 mg KRKA D.D. NOVO MESTO CIPROCIN 250 mg 250 mg E.I.P.I.CO. MED S.R.L. CIPROFLOXACIN 250 mg 250 mg LAROPHARM SRL CIPROFLOXACINA ALKALOID 250 mg ALKALOID D.O.O. 250 mg
CIPROLEN(R) 250 mg 250 mg AC HELCOR SRL CIPROLET 250 mg 250 mg DR. REDDY'S LABORATORIES CIPROZONE 250 mg 250 mg OZONE LABORATORIES LTD. CUMINOL 250 mg 250 mg GEDEON RICHTER ROMANIA J01MA02 CIPROFLOXACINUM SOL. PERF. 2 mg/ml CIPROBAY(R) 400 2 mg/ml BAYER HEALTHCARE AG UFEXIL 2 mg/ml DEMO SA
CIPRINOL(R) 400 mg/200 ml KRKA D.D. J01MA02 CIPROFLOXACINUM COMPR. FILM. 500 mg CIFRAN 500 mg RANBAXY UK LIMITED CIPHIN 500 500 mg ZENTIVA A.S. CIPRINOL 500 mg 500 mg KRKA D.D. NOVO MESTO CIPRO QUIN(R) 500 mg ANTIBIOTICE SA CIPROBAY(R) 500 500 mg BAYER HEALTHCARE AG CIPROCIN 500 mg 500 mg E.I.P.I.CO. MED S.R.L CIPRODAR 500 mg DAR AL DAWA PHARMA S.R.L CIPROFLOXACINA ALKALOID 500 mg ALKALOID D.O.O. 500 mg
CIPROLEN(R) 500 mg 500 mg AC HELCOR SRL CIPROLET 500 mg 500 mg DR. REDDY'S LABORATORIES CIPROZONE FORTE 500 mg 500 mg OZONE LABORATORIES LTD. CUMINOL 500 mg 500 mg GEDEON RICHTER ROMANIA SIFLOKS(R) 500 mg ECZACIBASI ILAC SANAYI VE TICARET AS J01MA02 CIPROFLOXACINUM COMPR. FILM. 750 mg CIPRINOL 750 mg 750 mg KRKA D.D. NOVO MESTO ________________________________________________________________________________
| 694 |J01MA14| MOXIFLOXACINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01MA14 MOXIFLOXACINUM COMPR. FILM. 400 mg AVELOX(R) 400 mg 400 mg BAYER HEALTHCARE AG
AVELOX(R) 400 mg/250 ml 400 mg/250 ml BAYER HEALTHCARE AG ________________________________________________________________________________
| 696 |J04AB01| CICLOSERINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J04AB01 CICLOSERINUM CAPS. 250 mg CICLOSERINA ANTIBIOTICE 250 mg ANTIBIOTICE S.A. 250 mg
HELPOCERIN 250 mg HELP PHARMACEUTICALS LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 697 |J04AB02| RIFAMPICINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J04AB02 RIFAMPICINUM CAPS. 150 mg SINERDOL 150 mg 150 mg ANTIBIOTICE SA
SINERDOL 300 mg 300 mg ANTIBIOTICE SA ________________________________________________________________________________
| 698 |J04AB04| RIFABUTINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J04AB04 RIFABUTINUM CAPS. 150 mg MYCOBUTIN 150 mg 150 mg PFIZER EUROPE MA EEIG ________________________________________________________________________________ ______________________________________________________________________________ | 699 |J04AB30| CAPREOMYCINUM (4) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J04AB30 CAPREOMYCINUM ________________________________________________________________________________
| 700 |J04AC01| ISONIAZIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J04AC01 ISONIAZIDUM COMPR. 100 mg ISONIAZIDA 100 mg 100 mg ANTIBIOTICE SA
ISONIAZIDA 300 mg ANTIBIOTICE SA J04AC01 ISONIAZIDUM SOL. INJ. 500 mg/10 ml IZONIAZIDA 500 mg 500 mg/10 ml TERAPIA SA ________________________________________________________________________________
| 701 |J04AD01| PROTIONAMIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J04AD01 PROTIONAMIDUM COMPR. FILM. 250 mg PROTIONAMIDA 250 mg 250 mg ANTIBIOTICE SA ________________________________________________________________________________ ______________________________________________________________________________ | 702 |J04AK01| PYRAZINAMIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J04AK01 PYRAZINAMIDUM COMPR. 500 mg PIRAZINAMIDA ANTIBIOTICE 500 mg ANTIBIOTICE S.A. 500 mg
________________________________________________________________________________ ______________________________________________________________________________ | 703 |J04AK02| ETHAMBUTOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J04AK02 ETHAMBUTOLUM COMPR. FILM. 250 mg ETAMBUTOL 250 mg 250 mg ANTIBIOTICE SA ________________________________________________________________________________ ______________________________________________________________________________ | 704 |J04AM02| COMBINATII (RIFAMPICINUM + IZONIAZIDUM) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J04AM02 COMBINATII CAPS. 300 mg + 150 mg (RIFAMPICINUM + IZONIAZIDUM) SINERDOLISO 300 mg + 150 mg ANTIBIOTICE SA ________________________________________________________________________________ SUBLISTA C2 - P3: PROGRAMUL NAŢIONAL DE ONCOLOGIE. ______________________________________________________________________________ | 705 |G03HA01| CYPROTERONUM | Protocol: L025C | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ G03HA01 CYPROTERONUM COMPR. 50 mg ANDROCUR 50 mg SCHERING AG ________________________________________________________________________________ ______________________________________________________________________________ | 706 |L01AA01| CYCLOPHOSPHAMIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. 1 g INJ./PERF. ENDOXAN(R) 1 g 1 g BAXTER ONCOLOGY GMBH L01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. 200 mg PERF./INJ. I.V. ENDOXAN 200 mg 200 mg ACTAVIS S.R.L.
INJ./PERF. ENDOXAN(R) 500 mg 500 mg BAXTER ONCOLOGY GMBH
ENDOXAN(R) 50 mg 50 mg BAXTER ONCOLOGY GMBH ________________________________________________________________________________
| 707 |L01AA02| CHLORAMBUCILUM | | |_______|_______|____________________________________________|_________________|
Yüklə 4,39 Mb. Dostları ilə paylaş:
|